Randomized Trialhigh evidence

Effect of Early Administration of Shenfu Injection on Hemodynamics in Septic Patients: A Multicenter, Randomized, Controlled Trial.

Critical care medicine·July 15, 2026·PMID 42456111

Why it matters

Sepsis remains a leading cause of ICU mortality, and adjunctive therapies that improve microcirculation and survival are needed. SFI, a traditional Chinese medicine, showed a mortality benefit without reducing vasopressor doses, suggesting mechanisms beyond hemodynamic support.

Infographic summary of Effect of Early Administration of Shenfu Injection on Hemodynamics in Septic Patients: A Multicenter, Randomized, Controlled Trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled